SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-026190
Filing Date
2024-06-03
Accepted
2024-06-03 11:57:27
Documents
3
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1717430239.html 3  
1 FORM 3 wk-form3_1717430239.xml 3 2249
2 EX-24 eisnermark-section16powe.htm EX-24 4263
3 eisnermark-section16powe001.jpg GRAPHIC 213652
  Complete submission text file 0001628280-24-026190.txt   302367
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Eisner Mark (Reporting) CIK: 0001834161 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 241012676